Trial intelligence / Profile preview

Ramipril and Candesartan in Cardiopulmonary Bypass

NCT00607672Phase 4Completed

Sponsor
Vanderbilt University
Start
Aug 2006
Primary completion
Aug 2011
Modality
Prodrugs/Conditional Activator Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ramipril, candesartan in Systemic Inflammatory Response Syndrome (SIRS), coagulopathy, sponsored by Vanderbilt University. Started Aug 2006; status: completed.

02

Drugs

ramiprilcandesartan
03

Conditions

Systemic Inflammatory Response Syndrome (SIRS)coagulopathy

Beyond the preview

Go deeper on NCT00607672.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00607672.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call